Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Bluebird Bio Stock Plunged Today

TheMotleyFool

0 0

Shares of Bluebird Bio (NASDAQ: BLUE) were plunging 19.3% lower as of 3:42 p.m. EST on Monday. The sharp decline came after two analysts downgraded Bluebird.

Goldman Sachs (NYSE: GS) analyst Salveen Richter downgraded the biotech stock from neutral to sell. Richter set a price target of $10, nearly 24% below Bluebird's closing price on Friday.

Morgan Stanley (NYSE: MS) analyst Matthew Harrison also downgraded the stock from equal weight to underweight (the equivalent of a sell recommendation). Harrison established a price target of $11, roughly 16% lower than Bluebird's closing price on Friday.

Source Fool.com

Like: 0

BLUE

Share